Ajanta Pharma Limited (NSE:AJANTPHARM)

Ajanta Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	454,741	350,323	327,581	280,899	154,878	154,667
Market Cap Growth	35.68%	6.94%	16.62%	81.37%	0.14%	-0.25%
Enterprise Value	450,769	343,381	320,489	276,473	149,016	149,244
Last Close Price	3639.80	2779.64	2570.36	2166.41	1143.51	1135.59

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	40.08	33.17	35.59	34.42	26.34	21.70
Forward PE	34.89	29.29	31.53	31.03	20.52	19.55
PS Ratio	7.87	6.43	7.05	6.67	4.14	4.63
PB Ratio	10.04	7.74	8.64	7.87	4.57	4.74
P/TBV Ratio	10.14	7.81	8.75	7.91	4.58	4.75
P/FCF Ratio	277.23	213.57	39.03	44.40	25.08	37.46
P/OCF Ratio	85.93	66.20	28.31	35.78	19.55	27.54
PEG Ratio	-	1.79	1.58	1.55	2.89	1.49

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	7.80	6.30	6.90	6.57	3.98	4.47
EV/EBITDA Ratio	28.76	23.29	25.59	23.76	18.74	16.27
EV/EBIT Ratio	32.17	25.88	28.40	26.44	21.92	18.47
EV/FCF Ratio	274.81	209.34	38.19	43.70	24.13	36.15

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.06	0.06	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	0.17	0.18	0.04	0.03	0.05	0.04
Debt / FCF Ratio	-	1.62	0.06	0.06	0.06	0.08
Net Debt / Equity Ratio	-0.09	-0.09	-0.15	-0.12	-0.24	-0.09
Net Debt / EBITDA Ratio	-0.25	-0.27	-0.45	-0.36	-1.01	-0.32
Net Debt / FCF Ratio	-	-2.42	-0.67	-0.67	-1.30	-0.71
Asset Turnover	-	0.98	0.96	0.90	0.86	0.85
Inventory Turnover	-	1.37	1.32	1.36	1.38	1.14
Quick Ratio	-	1.88	1.85	1.98	1.71	2.15
Current Ratio	-	2.64	2.85	3.05	2.49	3.50
Return on Equity (ROE)	-	25.39%	25.02%	23.47%	17.68%	22.77%
Return on Assets (ROA)	-	14.85%	14.61%	14.03%	9.73%	12.89%
Return on Invested Capital (ROIC)	25.78%	27.64%	27.41%	26.73%	19.30%	22.50%
Return on Capital Employed (ROCE)	-	28.00%	28.10%	27.90%	19.20%	23.70%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	2.50%	3.01%	2.81%	2.91%	3.80%	4.61%
FCF Yield	0.36%	0.47%	2.56%	2.25%	3.99%	2.67%
Dividend Yield	0.77%	1.01%	1.09%	1.66%	0.61%	0.56%
Payout Ratio	-	33.12%	37.96%	78.68%	15.25%	11.54%
Buyback Yield / Dilution	-0.01%	0.18%	0.66%	1.65%	1.19%	0.74%
Total Shareholder Return	0.76%	1.19%	1.75%	3.31%	1.80%	1.29%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 21, 2026

Data Sources Report a data error